Detalles de la búsqueda
1.
Strike early-strike strong lipid-lowering strategy with PCSK9i in ACS patients. Real-world evidence from AT-TARGET-IT registry.
Eur J Prev Cardiol
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38788773
2.
Efficacy, safety, adherence and persistence of PCSK9 inhibitors in clinical practice: A single country, multicenter, observational study (AT-TARGET-IT).
Atherosclerosis
; 366: 32-39, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36696749
3.
Interventional catheterization after total cavopulmonary connection: experience in 68 patients.
J Interv Cardiol
; 25(6): 622-7, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22823475
4.
Visualization of multiple catheters with electroanatomical mapping reduces X-ray exposure during atrial fibrillation ablation.
Europace
; 13(7): 955-62, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21421574
5.
Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome?: a randomized comparison of Carto-Merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation.
Europace
; 12(8): 1098-104, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20400766
6.
Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study.
Minerva Cardioangiol
; 67(2): 94-101, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30895761
7.
Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation.
Circ Arrhythm Electrophysiol
; 1(4): 269-75, 2008 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19808418
Resultados
1 -
7
de 7
1
Próxima >
>>